Free Newsletter
Cipla could supply meds to GSK, Teva
Free newsletter via e-mail
Tools
Indian drugmaker Cipla is in talks with multinational and leading generic drug companies, including GlaxoSmithKline and Israel's Teva, to supply generic drugs, its chairman said Monday. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: